NEW YORK, June 15, 2016 /PRNewswire/ -- Committed to working alongside dermatologists, La Roche-Posay's North American Fondation encourages residents, fellows and practitioners with at least two years beyond training to develop innovative programs. The brand and a board of certified dermatologists awards 2-3 winners with grants for ground-breaking projects in dermatology.
The winners include: Cory Simpson, MD, PhD, Resident Physician, Department of Dermatology of University of Pennsylvania; Karen Yan Kuo, MD, Resident in Dermatology, Stanford School of Medicine; and Michele Zerah, MD, Internal Medicine/Dermatology Resident, PGY2, Medstar Washington Hospital Center.
Dr. Simpson was granted $10,000 for his project aimed at Keratinocytes and understanding mechanisms regulating this process and how it may be altered in aging, skin cancer, and disorders. "I'll translate my findings to a 3D skin model that replicates the normal histology of the epidermis within two weeks. With this unique platform I can assess effects of drug treatments or genetic manipulation," shares Simpson.
Dr. Yan Kuo received $5,000 for her study on Genome-Wide Meta-Analysis to provide new genetic markers for patients based on skin cancer risk and prevention. She explains, "We believe the knowledge of an individual's susceptibility of skin cancer will change health behaviors. Our dream is to use personal genotype information in clinic to alter behaviors and lower risk."
Dr. Zerah, who was granted 5,000 for his study, discusses: "This will directly measure Vitamin D levels to compare different regimens of supplementation. The results may change primary care practices on prescriptions and facilitate avenues of further research."
Winners were awarded at La Roche-Posay's North American Fondation Awards dinner during the 74th Annual American Academy of Dermatology Meeting in Washington, D.C.
About LA ROCHE-POSAY
Recommended by more than 25,000 dermatologists worldwide, La Roche-Posay offers a unique range of daily skincare developed with dermatologists to meet their standards in efficacy, tolerance and elegant textures for increased compliance. The products, which are developed using a strict formulation charter, include a minimal number of ingredients to reduce side effects and reactivity and are formulated with active ingredients at optimal concentrations for increased efficacy. Additionally, La Roche-Posay products undergo stringent clinical testing to guarantee efficacy and safety, even on sensitive skin. For additional information about La Roche-Posay, visit www.laroche-posay.us and "like" the Facebook page at www.facebook.com/LaRochePosayusa.
SOURCE La Roche-Posay